Connect with us
South Korean health officials recently approved the use of the country’s first domestically developed COVID-19 vaccine, meant for people 18 years and older. The outcome of a public-private partnership,...
The loss of smell was considered the hallmark symptom of COVID-19 in the early days of the pandemic when most patients reported it as the first...
Omicron’s BA.4 and BA.5 subvariants “substantially” escaped antibody responses in people previously infected with COVID-19 and the fully vaccinated and boosted, new research showed. The median neutralizing antibody...
All Americans ages 6 months and older are now eligible for COVID-19 vaccination after the Centers for Disease Control and Prevention (CDC) officially endorsed the administration...
All Americans ages 6 months and older are now eligible for COVID-19 vaccination after the Centers for Disease Control and Prevention (CDC) officially endorsed the administration...
A survey has found that people who did not get the vaccine had a lower rate of suffering severe COVID-19 amid the pandemic. The survey uploaded...
A new bivalent booster vaccine from Moderna promises to be a ‘turning point’ in the fight against the COVID-19 pandemic as cases continue to rise in...
Babies are at risk of suffering neurodevelopment problems when they become exposed to SARS-CoV-2 in the womb, according to a new study. The European Psychiatric Association...
No one wanted COVID-19. The pandemic has created misery, death and hardship, and it isn’t finished yet. Still, the lingering crisis has generated opportunities, by expediting...
The U.S. Food and Drug Administration granted emergency use authorization to AstraZeneca’s COVID-19 antibody drug Evusheld on Dec. 8, 2021. Infectious disease physician Patrick Jackson of...
Recent Comments